Ally for the Poor in an Unlikely Corner

Share
Through his work in poor countries, Andrew Witty, chief executive of GlaxoSmithKline, has positioned his company as the leader among drug makers in advancing world health issues.



By NY Times Business, Read More »

Tags: Drugs (Pharmaceuticals), English, GlaxoSmithKline PLC|GSK|NYSE, Third World and Developing Countries

This entry was posted in Business and tagged Drugs (Pharmaceuticals), English, GlaxoSmithKline PLC|GSK|NYSE, Third World and Developing Countries. Bookmark the permalink. Post a comment or leave a trackback: Trackback URL.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>